Literature DB >> 19219532

Sjögren's syndrome: an old tale with a new twist.

Byung Ha Lee1, Mauro A Tudares, Cuong Q Nguyen.   

Abstract

Sjögren's syndrome (SjS) is chronic autoimmune disease manifested by the loss of saliva and/or tear secretion by salivary and/or lacrimal glands, respectively. The pathogenesis of the disease remains elusive, perhaps due to the multiple triggers of the disease. However, substantial advances have been made in attempting to resolve the complexity of SjS using both animal models and human subjects. The primary objectives of this review are to provide a better understanding of the disease processes with major emphasis on the use of mouse models, how genetic predisposition plays a role in the natural history of the disease, as well as a presentation of new findings pertaining to the role of T(H)1, T(H)2, and T(H)17 cells in the pathogenesis of SjS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219532      PMCID: PMC3809016          DOI: 10.1007/s00005-009-0002-4

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  81 in total

Review 1.  Pathogenesis of Sjögren's syndrome.

Authors:  R I Fox; H I Kang
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

Review 2.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

3.  Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency.

Authors:  S C Pflugfelder; S C Tseng; J S Pepose; M A Fletcher; N Klimas; W Feuer
Journal:  Ophthalmology       Date:  1990-03       Impact factor: 12.079

4.  Detection of Epstein-Barr virus genomes in normal human lacrimal glands.

Authors:  C A Crouse; S C Pflugfelder; T Cleary; S M Demick; S S Atherton
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

5.  Sjögren's syndrome in MRL/l and MRL/n mice.

Authors:  R W Hoffman; M A Alspaugh; K S Waggie; J B Durham; S E Walker
Journal:  Arthritis Rheum       Date:  1984-02

6.  Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells.

Authors:  R Jonsson; A Tarkowski; K Bäckman; R Holmdahl; L Klareskog
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

7.  Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.

Authors:  J B Harley; E L Alexander; W B Bias; O F Fox; T T Provost; M Reichlin; H Yamagata; F C Arnett
Journal:  Arthritis Rheum       Date:  1986-02

8.  Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis.

Authors:  R I Fox; M Luppi; P Pisa; H I Kang
Journal:  J Rheumatol Suppl       Date:  1992-01

9.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  35 in total

1.  Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.

Authors:  Saeed Khalili; Younan Liu; Yoshinori Sumita; Ola M Maria; David Blank; Sharon Key; Eva Mezey; Simon D Tran
Journal:  Int J Biochem Cell Biol       Date:  2010-08-21       Impact factor: 5.085

Review 2.  Systems analysis of salivary gland development and disease.

Authors:  Melinda Larsen; Kenneth M Yamada; Kurt Musselmann
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 3.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

4.  Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.

Authors:  Yaping Ju; Hao Guo; Frances Yarber; Maria C Edman; Santosh Peddi; Srikanth Reddy Janga; J Andrew MacKay; Sarah F Hamm-Alvarez
Journal:  Bioconjug Chem       Date:  2019-08-23       Impact factor: 4.774

5.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

6.  Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Authors:  Margherita Sisto; Loredana Lorusso; Giuseppe Ingravallo; Roberto Tamma; Beatrice Nico; Domenico Ribatti; Simona Ruggieri; Sabrina Lisi
Journal:  J Mol Histol       Date:  2018-01-04       Impact factor: 2.611

7.  Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.

Authors:  Jing Zhou; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-19       Impact factor: 5.187

Review 8.  Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.

Authors:  Byung Ha Lee; Adrienne E Gauna; Kaleb M Pauley; Yun-Jong Park; Seunghee Cha
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

9.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

10.  Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.

Authors:  Jing Zhou; Bo Ra You; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-11-15       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.